Allworth Financial LP boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 3,679.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,617 shares of the company's stock after acquiring an additional 8,389 shares during the quarter. Allworth Financial LP's holdings in Bath & Body Works were worth $256,000 as of its most recent filing with the SEC.
Other large investors also recently bought and sold shares of the company. Golden State Wealth Management LLC raised its holdings in shares of Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after purchasing an additional 642 shares during the period. UMB Bank n.a. increased its holdings in Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after purchasing an additional 596 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in Bath & Body Works by 109.7% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,629 shares of the company's stock worth $63,000 after purchasing an additional 852 shares during the last quarter. Ancora Advisors LLC purchased a new stake in Bath & Body Works during the 4th quarter worth approximately $67,000. Finally, TD Private Client Wealth LLC grew its position in shares of Bath & Body Works by 34.9% in the 4th quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock worth $89,000 after acquiring an additional 593 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on the company. Morgan Stanley reduced their price target on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research report on Tuesday, May 6th. The Goldman Sachs Group reduced their price target on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Barclays reduced their price target on Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a research report on Friday, May 30th. Citigroup boosted their price target on Bath & Body Works from $36.00 to $42.00 and gave the stock a "buy" rating in a research report on Tuesday, May 20th. Finally, Raymond James Financial reduced their price target on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research report on Thursday, April 17th. Four analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat, Bath & Body Works presently has a consensus rating of "Moderate Buy" and an average price target of $42.00.
Check Out Our Latest Analysis on Bath & Body Works
Bath & Body Works Trading Up 0.3%
NYSE BBWI traded up $0.08 during trading hours on Friday, hitting $31.79. The company's stock had a trading volume of 4,055,565 shares, compared to its average volume of 5,252,643. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87. The company has a market capitalization of $6.73 billion, a PE ratio of 8.48, a price-to-earnings-growth ratio of 1.06 and a beta of 1.72. The company's 50-day simple moving average is $30.16 and its two-hundred day simple moving average is $32.30.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The company had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same quarter last year, the business posted $0.38 EPS. Bath & Body Works's quarterly revenue was up 2.9% compared to the same quarter last year. Research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were given a dividend of $0.20 per share. The ex-dividend date was Friday, June 6th. This represents a $0.80 annualized dividend and a yield of 2.52%. Bath & Body Works's payout ratio is 21.33%.
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
